Sensus Healthcare, Inc. (SRTS) stock
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3043% below fair value
$2.33−0.90 (-27.80%)
Close on Nov 13, 2026Market cap $38.27MP/E –Yield –
Sensus Healthcare r&d expenses
Research and development expenses are spending on new products and technology.
Sensus Healthcare's R&D Expenses for the twelve months ending Sep 30, 2026 was $5.69M, down 23.7% year over year. For fiscal 2025 it was $7.78M, up 84.5% from the year before. Over ten years it grew 18.2% a year on average. The highest annual figure on record is $7.78M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.78M | +84.5% |
| FY2024 | Dec 31, 2024 | $4.22M | +14.6% |
| FY2023 | Dec 31, 2023 | $3.68M | +6.3% |
| FY2022 | Dec 31, 2022 | $3.46M | +0.7% |
| FY2021 | Dec 31, 2021 | $3.44M | -17.4% |
| FY2020 | Dec 31, 2020 | $4.16M | -35.2% |
| FY2019 | Dec 31, 2019 | $6.42M | +2.5% |
| FY2018 | Dec 31, 2018 | $6.26M | +14.0% |
| FY2017 | Dec 31, 2017 | $5.49M | +201.0% |
| FY2016 | Dec 31, 2016 | $1.82M | +24.4% |
| FY2015 | Dec 31, 2015 | $1.47M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.11M | -39.2% |
| Q2 FY2026 | Jun 30, 2026 | $1.11M | -24.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.59M | -39.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.88M | +20.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.82M | +110.8% |
| Q2 FY2025 | Jun 30, 2025 | $1.47M | +69.9% |
| Q1 FY2025 | Mar 31, 2025 | $2.61M | +181.4% |
| Q4 FY2024 | Dec 31, 2024 | $1.56M | +130.6% |
| Q3 FY2024 | Sep 30, 2024 | $863.00K | -20.3% |
| Q2 FY2024 | Jun 30, 2024 | $866.00K | +5.4% |
| Q1 FY2024 | Mar 31, 2024 | $926.00K | -15.7% |
| Q4 FY2023 | Dec 31, 2023 | $677.00K | -41.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.08M | +45.2% |
| Q2 FY2023 | Jun 30, 2023 | $822.00K | -0.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.10M | +50.8% |
| Q4 FY2022 | Dec 31, 2022 | $1.16M | +4.7% |
| Q3 FY2022 | Sep 30, 2022 | $746.00K | +0.3% |
| Q2 FY2022 | Jun 30, 2022 | $827.00K | -10.6% |
| Q1 FY2022 | Mar 31, 2022 | $728.00K | +10.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.11M | +31.2% |
| Q3 FY2021 | Sep 30, 2021 | $744.00K | -20.9% |
| Q2 FY2021 | Jun 30, 2021 | $925.00K | -19.4% |
| Q1 FY2021 | Mar 31, 2021 | $661.00K | -46.0% |
| Q4 FY2020 | Dec 31, 2020 | $843.00K | -11.2% |
| Q3 FY2020 | Sep 30, 2020 | $941.00K | -40.0% |
| Q2 FY2020 | Jun 30, 2020 | $1.15M | -40.7% |
| Q1 FY2020 | Mar 31, 2020 | $1.23M | -37.7% |
| Q4 FY2019 | Dec 31, 2019 | $949.67K | -36.0% |
| Q3 FY2019 | Sep 30, 2019 | $1.57M | -8.5% |
| Q2 FY2019 | Jun 30, 2019 | $1.93M | +23.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.97M | +31.2% |
| Q4 FY2018 | Dec 31, 2018 | $1.48M | -12.4% |
| Q3 FY2018 | Sep 30, 2018 | $1.71M | +14.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.57M | +35.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.50M | +31.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.70M | +133.0% |
| Q3 FY2017 | Sep 30, 2017 | $1.50M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $727.36K | – |
See a number that looks wrong?